Document:

exv10w3

Exhibit 10.3

CIRRUS LOGIC, INC.

2006 STOCK INCENTIVE PLAN

STOCK OPTION AGREEMENT

     This Stock Option Agreement (this “Agreement”) is made and entered into as of the Date of
Grant set forth in the related Notice of Grant of Stock Option (“Notice of Grant”) by and between
Cirrus Logic, Inc., a Delaware corporation (the “Company”), and you as the Holder named in the
Notice of Grant (“Holder”):

     WHEREAS, the Company, in order to induce you to enter into and/or continue in service to the
Company or its Affiliates in the capacity of Employee, Consultant, or Director, as applicable
(“Service”) and to materially contribute to the success of the Company, agrees to grant you an
option to acquire an interest in the Company through the purchase of shares of common stock of the
Company;

     WHEREAS, the Company adopted the Cirrus Logic, Inc. 2006 Stock Incentive Plan, as it may be
amended from time to time (the “Plan”), under which the Company is authorized to grant stock
options to certain employees and service providers of the Company and its Affiliates;

     WHEREAS, a copy of the Plan has been furnished to you and shall be deemed a part of this
Agreement as if fully set forth herein and terms capitalized but not defined herein shall have the
meaning set forth in the Plan; and

     WHEREAS, you desire to accept the option created pursuant to this Agreement.

     NOW, THEREFORE, in consideration of the mutual covenants set forth herein and for other
valuable consideration hereinafter set forth, the parties agree as follows:

     1. The Grant. Subject to the conditions set forth below, the Company hereby grants to
you, effective as of the Date of Grant set forth in the Notice of Grant, as a matter of separate
inducement and not in lieu of any salary or other compensation for your services to the Company,
the right and option to purchase (the “Option”), in accordance with the terms and conditions set
forth herein and in the Plan, an aggregate of the number of shares of Common Stock set forth in the
Notice of Grant (the “Option Shares”), at the Exercise Price set forth in the Notice of Grant (the
“Exercise Price”).

     2. Exercise.

          (a) Subject to the relevant provisions and limitations contained herein and in the Plan, you
may exercise the Option to purchase all or a portion of the applicable number of Vested Shares at
any time prior to the termination of the Option pursuant to this Agreement. Option Shares shall be
deemed “Nonvested Shares” unless and until they have become “Vested Shares” in accordance with the
vesting schedule set forth in the Notice of Grant, provided that you remain in the Service of the
Company or its Affiliates until the applicable dates set forth therein. In no event shall you be
entitled to exercise the Option for any Nonvested Shares or for a fraction of a Vested Share. For
administrative or other reasons, the Company may from time to time suspend the ability to exercise
options for limited periods of time, and the Committee may

 

 

provide for reasonable limitations on the number of requested exercises during any monthly or
weekly period.

          (b) Any exercise of the Option by you shall be made by delivery to the Company’s stock plan
administrator of (i) a completed notice of exercise in such form as may be prescribed by the
Committee, which shall specify the number of Option Shares in respect of which the Option is being
exercised and such other information and/or representations as may be required by the Committee,
and (ii) payment of the aggregate Exercise Price for the Option Shares purchased pursuant to the
exercise.

          (c) Payment of the Exercise Price may be made, at your election, with the approval of the
Company, (i) in cash, by certified or official bank check or by wire transfer of immediately
available funds, (ii) by delivery to the Company of a number of shares of Common Stock having a
Fair Market Value as of the date of exercise equal to the Exercise Price (provided that such Common
Stock used for this purpose must have been held by you for such minimum period of time as may be
established from time to time by the Committee), (iii) through a “cashless exercise” in accordance
with a Company established policy or program for the same, or (iv) any combination of the
foregoing.

          (d) If you are on leave of absence for any reason, the Company may, in its sole discretion,
determine that you will be considered to still be in the Service of the Company, provided that,
except as otherwise determined by the Committee, rights to the Option will be limited to the extent
to which those rights were earned or vested when the leave of absence began.

          (e) The Option shall in all events terminate at the close of business on the Expiration Date
set forth in the Notice of Grant (the “Expiration Date”).

     3. Effect of Termination of Service on Exercisability. Except as provided in Sections
6 and 7, this Option may be exercised only while you remain in the Service of the Company or any
Affiliate and will terminate and cease to be exercisable upon termination of your Service, except
as follows:

          (a) Termination on Account of Disability. If your Service with the Company or any
Affiliate terminates by reason of disability (within the meaning of section 22(e)(3) of the Code),
this Option may be exercised by you (or your estate or the person who acquires this Option by will
or the laws of descent and distribution or otherwise by reason of your death) at any time during
the period ending on the earlier to occur of (i) the date that is twelve (12) months following such
termination, or (ii) the Expiration Date, but only to the extent this Option was exercisable for
Vested Shares as of the date your Service so terminates. You will not be considered to have
terminated your Service by reason of disability unless you furnish proof of such impairment
sufficient to satisfy the Committee in its discretion.

          (b) Termination on Account of Death. If your Service with the Company or any
Affiliate terminates by reason of your death, your estate, or the person who acquires this Option
by will or the laws of descent and distribution or otherwise by reason of your death, may exercise
this Option at any time during the period ending on the earlier to occur of (i) the date

2

 

that is twelve (12) months following your death, or (ii) the Expiration Date, but only to the
extent this Option was exercisable for Vested Shares as of the date of your death.

          (c) Termination not for Cause. If your Service with the Company or any Affiliate
terminates for any reason other than as described in Sections 3(a) or (b), unless such Service is
terminated for Cause (as defined below), this Option may be exercised by you at any time during the
period ending on the earlier to occur of (i) the date that is three (3) months following your
termination, or (ii) the Expiration Date, or by your estate (or the person who acquires this Option
by will or the laws of descent and distribution or otherwise by reason of your death) during a
period of twelve (12) months following your death if you die during such three-month period, but in
each such case only to the extent this Option was exercisable for Vested Shares as of the date of
your termination. “Cause” means “cause” as defined in your employment agreement, if any, with the
Company or an Affiliate, or in the absence of such an agreement or such a definition, “Cause” will
mean a determination by the Committee that you (A) have engaged in personal dishonesty, willful
violation of any law, rule, or regulation (other than minor traffic violations or similar
offenses), or breach of fiduciary duty involving personal profit, (B) have been convicted of, or
plead nolo contendere to, any felony or a crime involving moral turpitude,(C) have engaged in
negligence or willful misconduct in the performance of your duties, including but not limited to
willfully refusing without proper legal reason to perform your duties and responsibilities, (D)
have materially breached any corporate policy or code of conduct established by the Company or any
Affiliate as such policies or codes may be adopted from time to time, (E) have violated the terms
of any confidentiality, nondisclosure, intellectual property, nonsolicitation, noncompetition,
proprietary information or inventions agreement, or any other agreement between you and the Company
or any Affiliate related to your Service with the Company or any Affiliate, or (F) have engaged in
conduct that is likely to have a deleterious affect on the Company or any Affiliate or their
legitimate business interests, including but not limited to their goodwill and public image. Your
Service with the Company shall be deemed to have been terminated for Cause effective as of your
date of termination if facts and circumstances are discovered after your Service has terminated
that would have justified a termination for Cause as of your date of termination.

     4. Non-Transferability. The Option, and any rights or interests therein, may not be
transferred in any manner except by will or the laws of descent and distribution or to the extent
approved by the Committee in accordance with the terms of the Plan.

     5. Compliance with Securities Law. Notwithstanding any provision of this Agreement to
the contrary, the grant of the Option and the issuance of Common Stock will be subject to
compliance with all applicable requirements of federal, state, and foreign securities laws and with
the requirements of any stock exchange or market system upon which the Common Stock may then be
listed. The Option may not be exercised if the issuance of shares of Common Stock upon exercise
would constitute a violation of any applicable federal, state, or foreign securities laws or other
law or regulations or the requirements of any stock exchange or market system upon which the Common
Stock may then be listed. In addition, the Option may not be exercised unless (1) a registration
statement under the Securities Act of 1933, as amended (the “Act”), is at the time of exercise of
the Option in effect with respect to the shares issuable upon exercise of the Option or (2) in the
opinion of legal counsel to the Company, the shares issuable upon exercise of the Option may be
issued in accordance with the terms of an applicable exemption from the registration requirements
of the Act. YOU ARE CAUTIONED THAT THE

3

 

OPTION MAY NOT BE EXERCISED UNLESS THE FOREGOING CONDITIONS ARE SATISFIED. ACCORDINGLY, YOU
MAY NOT BE ABLE TO EXERCISE THE OPTION WHEN DESIRED EVEN THOUGH THE OPTION IS VESTED. The
inability of the Company to obtain from any regulatory body having jurisdiction the authority, if
any, deemed by the Company’s legal counsel to be necessary to the lawful issuance and sale of any
shares subject to the Option will relieve the Company of any liability in respect of the failure to
issue or sell such shares as to which such requisite authority has not been obtained. As a
condition to the exercise of the Option, the Company may require you to satisfy any qualifications
that may be necessary or appropriate to evidence compliance with any applicable law or regulation
and to make any representation or warranty with respect to such compliance as may be requested by
the Company.

     6. Extension if Exercise Prevented by Law. Notwithstanding Section 3, if the exercise
of the Option within the applicable time periods set forth in Section 3 is prevented by the
provisions of Section 5, the Option will remain exercisable until 30 days after the date you are
notified by the Company that the Option is exercisable, but in any event no later than the
Expiration Date. The Company makes no representation as to the tax consequences of any such
delayed exercise. You should consult with your own tax advisor as to the tax consequences of any
such delayed exercise.

     7. Extension if You are Subject to Section 16(b). Notwithstanding Section 3, if a
sale within the applicable time periods set forth in Section 3 of shares acquired upon the exercise
of the Option would subject you to suit under Section 16(b) of the Securities Exchange Act of 1934,
as amended, the Option will remain exercisable until the earliest to occur of (1) the 10th day
following the date on which a sale of such shares by you would no longer be subject to such suit,
(2) the 190th day after your termination of Service with the Company and any Affiliate, or (3) the
Expiration Date. The Company makes no representation as to the tax consequences of any such
delayed exercise. You should consult with your own tax advisor as to the tax consequences of any
such delayed exercise.

     8. Withholding Taxes. The Committee may, in its discretion, require you to pay to the
Company at the time of the exercise of an Option or thereafter, the amount that the Committee deems
necessary to satisfy the Company’s current or future obligation to withhold federal, state or local
income or other taxes that you incur by exercising an Option. In connection with such an event
requiring tax withholding, you may (a) direct the Company to withhold from the shares of Common
Stock to be issued to you the number of shares necessary to satisfy the Company’s obligation to
withhold taxes, that determination to be based on the shares’ Fair Market Value as of the date of
exercise; (b) deliver to the Company sufficient shares of Common Stock (based upon the Fair Market
Value as of the date of such delivery) to satisfy the Company’s tax withholding obligation; or (c)
deliver sufficient cash to the Company to satisfy its tax withholding obligations. If you elect to
use a Common Stock withholding feature you must make the election at the time and in the manner
that the Committee prescribes. The Committee may, at its sole option, deny your request to satisfy
withholding obligations through shares of Common Stock instead of cash. In the event the Committee
subsequently determines that the aggregate Fair Market Value (as determined above) of any shares of
Common Stock withheld or delivered as payment of any tax withholding obligation is insufficient to
discharge that tax withholding obligation, then you shall pay to the Company, immediately upon the

4

 

Committee’s request, the amount of that deficiency in the form of payment requested by the
Committee.

     9. Status of Common Stock. With respect to the status of the Common Stock, at the
time of execution of this Agreement you understand and agree to all of the following:

          (a) You agree that the shares of Common Stock that you may acquire by exercising this Option
will not be sold or otherwise disposed of in any manner that would constitute a violation of any
applicable securities laws, whether federal or state. You also agree that the certificates
representing the shares of Common Stock purchased under this Option may bear such legend or legends
as the Committee deems appropriate to assure compliance with applicable securities laws.

          (b) You agree that (1) the Company may refuse to register the transfer of the shares of Common
Stock purchased under this Option on the stock transfer records of the Company if such proposed
transfer would in the opinion of counsel satisfactory to the Company constitute a violation of any
applicable securities law and (2) the Company may give related instructions to its transfer agent,
if any, to stop registration of the transfer of the shares of Common Stock purchased under this
Option.

     10. Notice of Sales Upon Disqualifying Disposition of ISO. If the Option is
designated as an Incentive Stock Option in the Notice of Grant, you must comply with the provisions
of this Section. You must promptly notify the Company in writing if you dispose of any of the
shares acquired pursuant to the Option within one year after the date you exercise all or part of
the Option or within two years after the Date of Grant. Until such time as you dispose of such
shares in a manner consistent with the provisions of this Agreement, unless otherwise expressly
authorized by the Company, you must hold all shares acquired pursuant to the Option in your name
(and not in the name of any nominee) for the one-year period immediately after the exercise of the
Option and the two-year period immediately after the Date of Grant. At any time during the
one-year or two-year periods set forth above, the Company may place a legend on any certificate
representing shares acquired pursuant to the Option requesting the transfer agent for the Company’s
stock to notify the Company of any such transfers. Your obligation to notify the Company of any
such transfer will continue notwithstanding that a legend has been placed on the certificate
pursuant to the preceding sentence.

     11. Right to Terminate Services. Nothing contained in this Agreement shall confer
upon you the right to continue in the employ of or performing services for the Company or any
Affiliate, or interfere in any way with the rights of the Company or any Affiliate to terminate
your employment or service relationship at any time.

     12. Furnish Information. You agree to furnish to the Company all information
requested by the Company to enable it to comply with any reporting or other requirement imposed
upon the Company by or under any applicable statute or regulation. You further agree to notify the
Company upon any change in the residence address indicated on the Notice of Grant.

     13. Dispute Resolution. The provisions of this Section shall be the exclusive means
of resolving disputes arising out of or relating to the Notice of Grant, the Plan, the Option and

5

 

this Agreement. The Company, you, and your assignees pursuant to Sections 3 and 4 (the
“parties”) shall attempt in good faith to resolve any disputes arising out of or relating to the
Notice of Grant, the Plan, the Option and this Agreement by negotiation between individuals who
have authority to settle the controversy. Negotiations shall be commenced by either party by
notice of a written statement of the party’s position and the name and title of the individual who
will represent the party. Within thirty (30) days of the written notification, the parties shall
meet at a mutually acceptable time and place, and thereafter as often as they reasonably deem
necessary, to resolve the dispute.

     Any controversy, dispute or claim that has not been settled by negotiation within thirty (30)
days of the written notification as set forth above shall be finally settled by arbitration under
the Commercial Arbitration Rules of the American Arbitration Association (“AAA”) by three
arbitrators. In such event, the claimant will deliver a written notice to the respondent(s) and
the AAA initiating arbitration and naming an arbitrator. Within twenty (20) days after receipt of
such arbitration notice, the respondent(s) shall name an arbitrator. Within twenty (20) days from
the naming of the two arbitrators, the two arbitrators shall name a third arbitrator. If there are
multiple claimants and/or multiple respondents, all claimants and/or all respondents shall attempt
to agree upon naming their respective arbitrator. If the claimants or respondents, as the case may
be, fail to name their respective arbitrator, or if the two arbitrators fail to name a third
arbitrator, or if within twenty (20) days after any arbitrator shall resign or otherwise cease to
serve as such a replacement arbitrator is not named by the party that originally named such
arbitrator, such arbitrator as to which agreement cannot be reached or as to which a timely
appointment is not made shall be named by the AAA. The place of arbitration shall be Austin,
Texas. The award of the arbitrators may be entered in any court of competent jurisdiction. The
costs of the arbitration shall be shared by the disputing parties equally. Notwithstanding
anything to the contrary herein, the arbitrators shall not award nor shall the Company have any
liability for any consequential, punitive, special, incidental, indirect or similar damages.

     14. Notices. Any notice required or permitted hereunder shall be given in writing and
shall be deemed effectively given upon personal delivery or upon deposit in the United States mail
by certified mail (if the parties are in the United States) or upon deposit for delivery by an
internationally recognized express mail courier service (for international delivery of notice),
with postage and fees prepaid, addressed to the other party at its address as such party may
designate in writing from time to time to the other party.

     15. No Liability for Good Faith Determinations. The Company and the members of the
Committee and the Board shall not be liable for any act, omission or determination taken or made in
good faith with respect to this Agreement or the Option granted hereunder.

     16. Execution of Receipts and Releases. Any payment of cash or any issuance or
transfer of shares of Common Stock or other property to you, or to your legal representative, heir,
legatee or distributee, in accordance with the provisions hereof, shall, to the extent thereof, be
in full satisfaction of all claims of such persons hereunder. The Company may require you or your
legal representative, heir, legatee or distributee, as a condition precedent to such payment or
issuance, to execute a release and receipt therefore in such form as it shall determine.

     17. No Guarantee of Interests. The Board and the Company do not guarantee the Common
Stock of the Company from loss or depreciation.

6

 

     18. Company Records. Records of the Company regarding your Service and other matters
shall be conclusive for all purposes hereunder, unless determined by the Company to be incorrect.

     19. Successors. This Agreement shall be binding upon you, your legal representatives,
heirs, legatees and distributees, and upon the Company, its successors and assigns.

     20. Severability. If any provision of this Agreement is held to be illegal or invalid
for any reason, the illegality or invalidity shall not affect the remaining provisions hereof, but
such provision shall be fully severable and this Agreement shall be construed and enforced as if
the illegal or invalid provision had never been included herein.

     21. Headings. The titles and headings of paragraphs are included for convenience of
reference only and are not to be considered in construction of the provisions hereof.

     22. Governing Law. All questions arising with respect to the provisions of this
Agreement shall be determined by application of the laws of the State of Delaware, without giving
any effect to any conflict of law provisions thereof, except to the extent Delaware law is
preempted by federal law. The obligation of the Company to sell and deliver Common Stock hereunder
is subject to applicable laws and to the approval of any governmental authority required in
connection with the authorization, issuance, sale, or delivery of such Common Stock.

     23. Electronic Delivery. The Company may, in its sole discretion, decide to deliver
any documents related to the Option granted under the Plan or future options that may be granted
under the Plan by electronic means or to request your consent to participate in the Plan by
electronic means. You hereby consent to receive such documents by electronic delivery and, if
requested, to agree to participate in the Plan through an on-line or electronic system established
and maintained by the Company or another third party designated by the Company.

     24. Word Usage. Words used in the masculine shall apply to the feminine where
applicable, and wherever the context of this Agreement dictates, the plural shall be read as the
singular and the singular as the plural.

     25. Miscellaneous.

          (a) This Agreement is subject to all the terms, conditions, limitations and restrictions
contained in the Plan. In the event of any conflict or inconsistency between the terms hereof and
the terms of the Plan, the terms of the Plan shall be controlling.

          (b) The Option may be amended by the Board or by the Committee at any time (i) if the Board or
the Committee determines, in its sole discretion, that amendment is necessary or advisable in light
of any addition to or change in any federal or state, tax or securities law or other law or
regulation, which change occurs after the Date of Grant and by its terms applies to the Option; or
(ii) other than in the circumstances described in clause (i) or provided in the Plan, with your
consent.

          (c) If this Option is designated as an Incentive Stock Option in the Notice of Grant, then in
the event the Option Shares (and all other options granted to you by the Company

7

 

or any parent of the Company or subsidiary that are designated as incentive stock options
within the meaning of section 422 of the Code) that first become exercisable in any calendar year
have an aggregate fair market value (determined for each Option Share as of the Date of Grant) that
exceeds $100,000, the Option Shares in excess of $100,000 shall be treated as subject to a
Nonstatutory Stock Option.

     By your signature below, or by your electronic acceptance of this Agreement, you agree to all
the terms and conditions of the Option, the Plan, and this Agreement. You acknowledge that you
have had the opportunity to review the Plan and this Agreement in their entirety and to obtain the
advice of counsel prior to executing this Agreement. You agree to accept as binding, conclusive
and final all decisions or interpretations of the Committee upon any questions relating to the
Option, the Plan, or this Agreement.

	 	 	 

	AGREED AND ACCEPTED:
	 
	 	 
	 
	Signature of Holder
	 
	 	 
	 
	Printed Name of Holder
	 
	 	 
	Date:
	 	 
	 

	 	 

8exv10w1

Exhibit 10.1

WARRANT EXERCISE AND STOCK ISSUANCE AGREEMENT

     THIS WARRANT EXERCISE AND STOCK ISSUANCE AGREEMENT (the “Agreement”) is effective as of this
7th day of October, 2010, by and between Resolute Energy Corporation, a Delaware corporation (the
“Company”), and [______________] (the “Holder”).

RECITALS

     WHEREAS, the Holder holds [__________] warrants (the “Warrants”) to purchase shares of the
Company’s common stock, par value $0.0001 per share (the “Common Stock”);

     WHEREAS, the Holder desires to (i) exercise an aggregate of [__________] Warrants and (ii)
tender to the Company an aggregate of [_________] Warrants to purchase [_________] shares of Common
Stock, subject to and in accordance with the terms set forth in this Agreement (the “Transaction”);
and

     WHEREAS, the Company desires to consummate the Transaction subject to and in accordance with
the terms set forth in this Agreement;

     NOW, THEREFORE, BE IT RESOLVED, that in consideration of the promises contained herein and for
other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereby agree as follows:

AGREEMENT

     1. Transaction. At the Closing, (i) the Holder hereby agrees to exercise [_______]
Warrants (the “Exercised Warrants”) at an exercise price of $13.00 per share, for an aggregate
exercise price of $[_______] (the “Cash Consideration”) and tender [_______] Warrants (the
“Exchanged Warrants”) to the Company and
(ii) the Company agrees to issue to the Holder an
aggregate of [_______] shares of Common Stock (the “Shares”), all as set forth below in Section 2.

     2. Closing.

          2.1 The date and time of the closing of the Transaction (the “Closing Date”) shall be 12:00
p.m., Denver, Colorado time, on October 22, 2010.

          2.2 On or prior to the Closing Date, the Holder agrees to (i) surrender or cause to be
surrendered to the Company, at the principal office of Continental Stock Transfer & Trust Company,
a New York corporation (the “Warrant Agent”), the Exercised Warrants through the facilities of the
Depository Trust Corporation (“DTC”) pursuant to instructions provided in writing to the Holder by
the Company; (ii) execute and deliver to the Warrant Agent the Form of Election to Purchase
included in Exhibit C to that certain Warrant Agreement by and between the Company and the Warrant
Agent; (iii) surrender or cause to be surrendered to the Company the Exchanged Warrants through the
facilities of the DTC pursuant to instructions provided in writing to the Holder by the Company;
and (iv) transfer to the Company an amount equal to the

 

 

Cash Consideration, by wire transfer of immediately available funds pursuant to instructions
provided in writing to the Holder by the Company.

          2.3 On the Closing Date, the Company agrees to deliver or cause to be delivered to the Holder
two certificates evidencing the Shares in the standard form of certificate for the Company’s common
stock. The first certificate shall represent [_______] shares of Common Stock, the purchase and
sale of which are the subject of the Company’s registration statement on Form S-1 (No. 333-166142)
(the “Registered Shares”). The second certificate shall represent [_______] shares of Common Stock
which have not been registered by the Company (the “Restricted Shares”)

     3. Representations and Warranties of the Company. The Company hereby represents and
warrants to the Holder as follows:

          3.1 Organization and Existence. The Company is duly organized, validly existing and
in good standing under the laws of the State of Delaware.

          3.2 Power and Authority; No Conflicts. The Company has the requisite corporate power
and authority to execute, deliver and perform this Agreement and to carry out the transactions
contemplated hereby. Such execution, delivery and performance will not (i) require the consent,
approval or authorization of any third party or any governmental authority, other than the filing
of any requisite notices and/or applications to the New York Stock Exchange for the issuance and
sale of the Shares and the surrender of the Warrants, (ii) violate or conflict with any provision
of the Amended and Restated Certificate of Incorporation and Bylaws of the Company, (iii) conflict
with, or constitute a default (or an event that with notice, or lapse of time, or both, would
become a default) under, or give to any person or entity any rights of termination, amendment,
acceleration or cancellation of, any agreement, indenture or instrument to which the Company is a
party, or (iv) result in a violation of any law, rule, regulation, order, judgment or decree
(including federal and state securities laws) applicable to the Company, except in the case of
clauses (iii) and (iv) above, for such conflicts, defaults, rights or violations that would not,
individually or in the aggregate, reasonably be expected to have a material adverse effect on the
ability of the Company to perform its obligations hereunder.

          3.3 Litigation. There is no action, suit, claim, proceeding, inquiry or investigation
before or by any court, government agency or self-regulatory organization or body pending or, to
the knowledge of Company, threatened against or affecting the Company or any of its officers or
directors acting as such that would, individually or in the aggregate, reasonably be expected to
have a material adverse effect on the ability of the Company to perform its obligations hereunder.

          3.4 Valid and Binding Obligations. This Agreement has been duly and validly executed
and delivered by the Company and, assuming the due execution, authorization and delivery by Holder,
constitutes the valid and binding obligation of the Company, enforceable against the Company in
accordance with its terms, except as enforceability may be limited by (i) applicable bankruptcy,
insolvency, reorganization, moratorium, fraudulent conveyance or other similar laws relating to or
affecting creditors’ rights generally and (ii) general principles of

2

 

equity (regardless of whether such enforceability is considered in a proceeding in equity or
at law).

          3.5 Valid Issuance. The issuance, sale and delivery of the Shares in accordance with
this Agreement have been duly authorized by all necessary corporate action on the part of the
Company, and the Shares, when so issued in accordance with this Agreement, will be duly and validly
issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the
issuance thereof. Assuming the validity and accuracy of the Holder’s representations and
warranties in this Agreement, the issuance by the Company of the Restricted Shares in accordance
with this Agreement is exempt from registration under the Securities Act of 1933, as amended (the
“Securities Act”). The Company has no contract, arrangement or understanding relating to, and will
not, directly or indirectly, pay any commission or other remuneration to any broker, dealer,
salesperson, agent or any other person for soliciting the tender of Holder’s Warrants.

          3.6 Registration Statement. The Company has filed with the Securities and Exchange
Commission (the “Commission”) a registration statement on Form S-1 (No. 333-166142) relating to the
issuance of up to 48,400,000 shares of the Company’s Common Stock upon exercise of the Public
Warrants, Sponsor’s Warrants and Founder’s Warrants (as such terms are defined therein) (the
“Warrant Share Registration Statement”); and such Warrant Share Registration Statement has been
declared effective by the Commission. No stop order suspending the effectiveness of the Warrant
Share Registration Statement has been issued and no proceeding for that purpose has been initiated
or threatened by the Commission. The Exercised Warrants constitute Public Warrants under the
Warrant Share Registration Statement, and the exercise of the Exercised Warrants is being made
pursuant to the Warrant Share Registration Statement.

     4. Representations and Warranties of the Holder. The Holder hereby represents and
warrants to the Company as follows:

          4.1 Organization and Existence. The Holder is duly organized, validly existing and in
good standing under the laws of the Cayman Islands.

          4.2 Power and Authority. The Holder has full power and authority to execute, deliver
and perform this Agreement and to carry out the transaction contemplated hereby, including the
authority to legally tender, sell, assign and transfer the Warrants. Such execution, delivery and
performance will not (i) require the consent, approval or authorization of any third party or any
governmental authority, (ii) violate or conflict with any provision of the Certificate of
Incorporation (or similar governing documents) of the Holder, (iii) conflict with, or constitute a
default (or an event that with notice, or lapse of time, or both, would become a default) under, or
give to any person or entity any rights of termination, amendment, acceleration or cancellation of,
any agreement, indenture or instrument to which the Holder is a party, or (iv) result in a
violation of any law, rule, regulation, order, judgment or decree (including federal and state
securities laws) applicable to the Holder, except in the case of clauses (iii) and (iv) above, for
such conflicts, defaults, rights or violations that would not, individually or in the aggregate,
reasonably be expected to have a material adverse effect on the ability of the Holder to perform
its obligations hereunder.

3

 

          4.3 Litigation. There is no action, suit, claim, proceeding, inquiry or investigation
before or by any court, government agency or self-regulatory organization or body pending or, to
the knowledge of Holder, threatened against or affecting the Holder or any of its officers or
directors acting as such that would, individually or in the aggregate, reasonably be expected to
have a material adverse effect on the ability of the Holder to perform its obligations hereunder.

          4.4 Valid and Binding Obligations. This Agreement has been duly and validly executed
and delivered by the Holder and, assuming the due execution, authorization and delivery by the
Company, constitutes the valid and binding obligation of the Holder, enforceable against the Holder
in accordance with its terms, except as enforceability may be limited by (i) applicable bankruptcy,
insolvency, reorganization, moratorium, fraudulent conveyance or other similar laws relating to or
affecting creditors’ rights generally and (ii) general principles of equity (regardless of whether
such enforceability is considered in a proceeding in equity or at law).

          4.5 Title. The Holder holds the Warrants free and clear of any liens, security
interests, encumbrances or other restrictions on transfer. The Holder has not entered into any
agreement which creates or will create upon transfer to the Company any lien, security interests,
encumbrances, notices, restrictions for transfer on the Warrants except such as are created by the
Company. The Company shall acquire good and marketable title to the Warrants being surrendered
hereunder, free and clear of any liens, security interests, pledges, claims, liabilities and
restrictions of any nature whatsoever (other than restrictions imposed by applicable securities
laws).

          4.6 Information. The Holder has reviewed the Company’s public filings with the
Commission and has received or has had full access to all the information it considers necessary or
appropriate to make an informed investment decision with respect to the Transaction. The Holder
further has had an opportunity to ask questions and receive answers from the Company regarding the
terms and conditions of the Transaction and to obtain additional information necessary to verify
any information furnished to the Holder or to which the Holder had access. Except as it pertains
to the Transaction, this Agreement and the facts, circumstances and negotiations giving rise to
thereto, Holder is not in possession of any material, nonpublic information received from the
Company, any of its subsidiaries or any of their respective officers, directors, employees or
agents.

          4.7 Regulation M. Holder is aware that the anti-manipulation rules of Regulation M
under the Exchange Act may apply to sales of Common Stock or Warrants and other activities with
respect to the Common Stock or Warrants by the Holder.

          4.8 Accredited Investor. Holder is (i) an “accredited investor” as that term is
defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933 (the “Securities
Act”), (ii) experienced in making investments of the kind described in this Agreement and the
related documents, (iii) able, by reason of the business and financial experience of its officers
and professional advisors (who are not affiliated with or compensated in any way by the Company or
any of its affiliates or selling agents), to protect its own interests in connection with the
transactions described in this Agreement and (iv) able to afford the entire

4

 

loss of its investment in the securities being purchased by the Holder from the Company. The
Holder is acquiring the Restricted Shares for investment and not with a view to the sale or
distribution thereof and understands that the Restricted Shares are restricted securities, as
defined in the Securities Act, and may not be sold or otherwise distributed except pursuant to an
effective registration statement or an exemption from the registration requirements of the
Securities Act and that the certificates for such securities shares will bear a legend in
substantially the following form:

     THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED (THE “SECURITIES ACT”), AND ACCORDINGLY, MAY NOT BE OFFERED OR SOLD
EXCEPT AS SET FORTH IN THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF, THE HOLDER
(1) AGREES THAT IT WILL NOT RESELL OR OTHERWISE TRANSFER THE SECURITY EVIDENCED
HEREBY, EXCEPT (A) TO THE ISSUER; (B) TO PERSONS OTHER THAN U.S. PERSONS OUTSIDE THE
UNITED STATES IN COMPLIANCE WITH REGULATION S UNDER THE SECURITIES ACT; (C) PURSUANT
TO THE EXEMPTION FROM REGISTRATION PROVIDED BY RULE 144 ADOPTED UNDER THE SECURITIES
ACT OR ANOTHER AVAILABLE EXEMPTION UNDER THE SECURITIES ACT (IF AVAILABLE); OR (D)
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, AND (2)
AGREES THAT IT WILL, PRIOR TO ANY TRANSFER OF THIS SECURITY, FURNISH TO THE ISSUER
OR ISSUER’S COUNSEL SUCH CERTIFICATIONS, LEGAL OPINIONS OR OTHER INFORMATION AS MAY
BE REQUIRED BY THE ISSUER TO CONFIRM THAT SUCH TRANSFER IS BEING MADE PURSUANT TO AN
EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF
THE SECURITIES ACT. AS USED HEREIN, THE TERMS ‘‘UNITED STATES’’ AND ‘‘U.S. PERSON’’
HAVE THE MEANING GIVEN TO THEM BY REGULATION S UNDER THE SECURITIES ACT. IN ANY
CASE, THE HOLDER HEREOF WILL NOT, DIRECTLY OR INDIRECTLY, ENGAGE IN ANY HEDGING
TRANSACTION WITH REGARD TO THIS SECURITY, EXCEPT AS PERMITTED BY THE SECURITIES ACT.

     5. Registration Rights.

          5.1 Definitions. For the purposes of this Agreement, the terms set forth below are
used herein as so defined:

          5.1.1 “Business Day” means a day other than a Saturday, Sunday or a day on which
commercial banks in Denver, Colorado are authorized or required by applicable Law to be
closed for business.

          5.1.2 “Exchange Act” means the Securities Exchange Act of 1934, as amended.

5

 

          5.1.3 “Registrable Securities” means: (i) the Restricted Shares and (ii) any security
issued with respect to such Restricted Shares upon any stock dividend, split, merger or
similar event, all of which Registrable Securities are subject to the rights provided herein
until such rights terminate pursuant to the provisions hereof. Any Registrable Security
will cease to be a Registrable Security upon the earliest to occur of (a) when a
registration statement covering such Registrable Security becomes or is declared effective
by the Commission and such Registrable Security has been sold or disposed of pursuant to
such effective registration statement; (b) when such Registrable Security has been sold or
transferred in a private transaction; (c) when such Registrable Security has been disposed
of pursuant to any section of Rule 144 (or any similar provision then in force) under the
Securities Act; or (d) one year after the Closing Date.

          5.1.4 “Registration Expenses” means all expenses incident to the Company’s performance
under or compliance with this Agreement to effect the registration of Registrable Securities
on the Shelf Registration Statement pursuant to Section 5.3 and the disposition of
such securities, including, without limitation, all registration, filing, securities
exchange listing and New York Stock Exchange fees, all registration, filing, qualification
and other fees and expenses of complying with securities or blue sky laws, fees of the
Financial Industry Regulatory Authority, fees of transfer agents and registrars, all word
processing, duplicating and printing expenses, any transfer taxes and the fees and
disbursements of counsel and independent public accountants for the Company, including the
expenses of any special audits or “cold comfort” letters required by or incident to such
performance and compliance.

          5.1.5 “Selling Expenses” means all underwriting fees, discounts and selling commissions
or similar fees or arrangements allocable to the sale of the Registrable Securities.

          5.1.6 “Shelf Registration Statement” means a registration statement under the
Securities Act to permit the public resale of the Registrable Securities from time to time,
including as permitted by Rule 415 under the Securities Act (or any similar provision then
in force under the Securities Act).

          5.2 Rights and Obligations. All rights and obligations of the Holder under this
Section 5, and all rights and obligations of the Company under this Section 5 with
respect to the Holder, shall terminate upon the termination of the Effectiveness Period (as defined
below).

          5.3 Deadline To Become Effective. As soon as practicable following the Closing Date,
but in any event within 45 days of the Closing Date, the Company shall prepare and file a Shelf
Registration Statement under the Securities Act with respect to all of the Registrable Securities.
The Shelf Registration Statement filed pursuant to this Section 5.3 shall be on such
appropriate registration form of the Commission as shall be selected by the Company. The Company
shall use its commercially reasonable efforts to cause the Shelf Registration Statement to become
effective as soon as practicable but no later than 180 days following the Closing Date (the “Target
Effective Date”). The Company will use its commercially reasonable efforts to cause the Shelf
Registration Statement filed pursuant to this Section 5.3 to be continuously effective
under the Securities Act until the earlier of (i) the date as of which all

6

 

Registrable Securities are sold by the Holder and (ii) the date as of which all Registrable
Securities cease to be Registrable Securities (the “Effectiveness Period”). The Shelf Registration
Statement when declared effective (including the documents incorporated therein by reference) will
comply as to form in all material respects with all applicable requirements of the Securities Act
and the Exchange Act and will not contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein not
misleading (and, in the case of any prospectus contained in such Shelf Registration Statement, in
the light of the circumstances under which a statement is made). As soon as practicable following
the date that the Shelf Registration Statement becomes effective, but in any event within five (5)
Business Days of such date, the Company shall provide the Holder with written notice of the
effectiveness of the Shelf Registration Statement.

          5.4 Delay Rights. Notwithstanding anything to the contrary contained herein, the
Company may, upon written notice to the Holder, suspend the Holder’s use of any prospectus which is
a part of the Shelf Registration Statement (in which event the Holder shall discontinue sales of
the Registrable Securities pursuant to the Shelf Registration Statement but may settle any
previously made sales of Registrable Securities) if (i) the Company is pursuing an acquisition,
merger, reorganization, disposition or other similar transaction and the Company determines in good
faith that the Company’s ability to pursue or consummate such a transaction would be materially
adversely affected by any required disclosure of such transaction in the Shelf Registration
Statement or (ii) the Company has experienced some other material non-public event the disclosure
of which at such time, in the good faith judgment of the Company, would materially adversely affect
the Company; provided, however, in no event shall the Holder be suspended from selling Registrable
Securities pursuant to the Shelf Registration Statement for a period that exceeds an aggregate of
60 days in any 180-day period or 90 days in any 365-day period. Upon disclosure of such
information or the termination of the condition described above, the Company shall provide prompt
notice to the Holder and shall promptly terminate any suspension of sales it has put into effect
and shall take such other reasonable actions to permit registered sales of Registrable Securities
as contemplated in this Agreement.

          5.5 No Demand Rights. Notwithstanding any other provision of this Agreement, the
Holder shall not be entitled to any “demand” rights or similar rights that would require the
Company to effect an underwritten offering upon the demand of the Holder.

          5.6 In connection with its obligations under this Section 5, the Company will use its
commercially reasonable efforts to:

          5.6.1 prepare and file with the Commission such amendments and supplements to the Shelf
Registration Statement and the prospectus used in connection therewith as may be necessary
to keep the Shelf Registration Statement effective for the Effectiveness Period and as may
be necessary to comply with the provisions of the Securities Act with respect to the
disposition of all securities covered by the Shelf Registration Statement;

          5.6.2 furnish to the Holder (i) upon request and subject to appropriate confidentiality
obligations, copies of reasonably complete drafts of all such documents proposed to be filed
(including exhibits and each document incorporated by reference

7

 

therein to the extent then required by the rules and regulations of the Commission),
and provide the Holder the opportunity to object to any information pertaining to the Holder
and its plan of distribution that is contained therein and make the corrections reasonably
requested by the Holder with respect to such information prior to filing the Shelf
Registration Statement or supplement or amendment thereto, and (ii) such number of copies of
the Shelf Registration Statement and the prospectus included therein and any supplements and
amendments thereto as the Holder may reasonably request in order to facilitate the public
sale or other disposition of the Registrable Securities covered by such Shelf Registration
Statement;

          5.6.3 if applicable, use its commercially reasonable efforts to register or qualify the
Registrable Securities covered by the Shelf Registration Statement under the securities or
blue sky laws of such jurisdictions as the Holder shall reasonably request; provided,
however, that the Company will not be required to qualify generally to transact business in
any jurisdiction where it is not then required to so qualify or to take any action which
would subject it to general service of process in any such jurisdiction where it is not then
so subject;

          5.6.4 notify the Holder, at any time when a prospectus relating thereto is required to
be delivered by it under the Securities Act, of (i) the filing of the Shelf Registration
Statement or any prospectus or prospectus supplement to be used in connection therewith, or
any amendment or supplement thereto, and, with respect to such Shelf Registration Statement
or any post-effective amendment thereto, when the same has become effective; and (ii) the
receipt of any written comments from the Commission with respect to any filing referred to
in clause (i) and any written request by the Commission for amendments or supplements to the
Shelf Registration Statement or any prospectus or prospectus supplement thereto;

          5.6.5 notify the Holder, at any time when a prospectus relating thereto is required to
be delivered under the Securities Act, of (i) the happening of any event as a result of
which the prospectus or prospectus supplement contained in the Shelf Registration Statement,
as then in effect, includes an untrue statement of a material fact or omits to state any
material fact required to be stated therein or necessary to make the statements therein not
misleading (in the case of any prospectus contained therein, in the light of the
circumstances under which a statement is made); (ii) the issuance or express threat of
issuance by the Commission of any stop order suspending the effectiveness of the Shelf
Registration Statement, or the initiation of any proceedings for that purpose; or (iii) the
receipt by the Company of any notification with respect to the suspension of the
qualification of any Registrable Securities for sale under the applicable securities or blue
sky laws of any jurisdiction. Following the provision of such notice, the Company agrees to
amend or supplement the prospectus or prospectus supplement or take other appropriate action
so that the prospectus or prospectus supplement does not include an untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary to
make the statements therein not misleading in the light of the circumstances then existing
and to take such other commercially reasonable action as is necessary to remove a stop
order, suspension, threat thereof or proceedings related thereto;

8

 

          5.6.6 upon request and subject to appropriate confidentiality obligations, furnish to
the Holder copies of any and all transmittal letters or other correspondence with the
Commission or any other governmental agency or self-regulatory body or other body having
jurisdiction (including any domestic or foreign securities exchange) relating to such
offering of Registrable Securities;

          5.6.7 otherwise use its commercially reasonable efforts to comply with all applicable
rules and regulations of the Commission, and make available to its security holders, as soon
as reasonably practicable, an earnings statement, which earnings statement shall satisfy the
provisions of Section 11(a) of the Securities Act and Rule 158 promulgated thereunder;

          5.6.8 cause all such Registrable Securities registered pursuant to this Agreement to be
listed on the New York Stock Exchange;

          5.6.9 use its commercially reasonable efforts to cause the Registrable Securities to be
registered with or approved by such other governmental agencies or authorities as may be
necessary by virtue of the business and operations of the Company to enable the Holder to
consummate the disposition of such Registrable Securities; and

          5.6.10 if requested by the Holder, (i) incorporate in a prospectus supplement or
post-effective amendment such information as the Holder reasonably requests to be included
therein relating to the sale and distribution of Registrable Securities, including
information with respect to the number of Registrable Securities being offered or sold, the
purchase price being paid therefor and any other terms of the offering of the Registrable
Securities to be sold in such offering; and (ii) make all required filings of such
prospectus supplement or post-effective amendment after being notified of the matters to be
incorporated in such prospectus supplement or post-effective amendment.

The Holder, upon receipt of notice from the Company of the happening of any event of the
kind described in Section 5.6.5, shall forthwith discontinue offers and sales of the
Registrable Securities until the Holder’s receipt of the copies of the supplemented or
amended prospectus contemplated by Section 5.6.5 or until it is advised in writing
by the Company that the use of the prospectus may be resumed and has received copies of any
additional or supplemental filings incorporated by reference in the prospectus, and, if so
directed by the Company, the Holder will, or will request the managing underwriter or
underwriters, if any, to deliver to the Company (at the Company’s expense) all copies in its
possession or control, other than permanent file copies then in the Holder’s possession, of
the prospectus covering such Registrable Securities current at the time of receipt of such
notice.

          5.7 Cooperation by Holder. The Company shall have no obligation to file the Shelf
Registration Statement if the Holder fails, upon request from the Company, to timely furnish such
information that the Company determines, after consultation with its counsel, is reasonably
required in order for the registration statement or prospectus supplement, as applicable, to comply
with the Securities Act.

9

 

          5.8 [RESERVED]

          5.9 Expenses. The Company will pay all reasonable Registration Expenses as determined
in good faith. The Holder shall pay its pro rata share of all Selling Expenses in connection with
any sale of its Registrable Securities hereunder. In addition, except as otherwise provided in
Section 6 hereof, the Company shall not be responsible for legal fees incurred by the
Holder in connection with the exercise of the Holder’s rights hereunder.

          5.10 Failure to Register. In the event that the Shelf Registration Statement has not
been declared effective before the Target Effective Date and the Company has failed to comply with
its obligations under Section 7 of this Agreement (the “Penalty Conditions”), then the
Company shall pay to the Holder, upon Holder’s demand, an amount in cash equal to .75% of the
aggregate fair market value (measured on a monthly basis by calculating the average daily closing
prices on the NYSE) of the Registrable Securities for each month that the Company has failed to
satisfy the Penalty Conditions; provided, however, for the avoidance of doubt, payment of any
amount pursuant to this Section 5.10 shall be due only for those months where Holder
continues to hold any Registrable Securities, and shall be pro-rated to the extent the Penalty
Conditions were only effective for a portion of the month, based on the number of trading days
Holder was unable to sell such Registrable Securities either pursuant to the Shelf Registration
Statement, Rule 144, or otherwise.

     6. Indemnification.

          6.1 By the Company. In the event of a registration of any Registrable Securities
under the Securities Act pursuant to this Agreement, the Company will indemnify and hold harmless
the Holder, its directors, officers, employees and agents and each Person, if any, who controls the
Holder and its directors, officers, employees or agents (collectively, the “Holder Indemnified
Persons”), against any losses, claims, damages, expenses or liabilities (including reasonable
attorneys’ fees and expenses) (collectively, “Losses”), joint or several, to which such Holder
Indemnified Person may become subject under the Securities Act, the Exchange Act or otherwise,
insofar as such Losses (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement of any
material fact (in the case of any prospectus, in light of the circumstances under which such
statement is made) contained in the Shelf Registration Statement, any preliminary prospectus,
prospectus supplement or final prospectus contained therein, or any amendment or supplement
thereof, (ii) the omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein (in the case of a prospectus, in light
of the circumstances under which they were made) not misleading, (iii) any misrepresentation or
breach of any representation or warranty made by the Company in this Agreement or (iv) any breach
of any covenant, agreement or obligation of the Company contained in this Agreement, other than the
obligations of the Company pursuant to Section 5, and will reimburse the Holder Indemnified
Persons for any legal or other expenses reasonably incurred by them in connection with
investigating or defending any such Loss or actions or proceedings; provided, however, that the
Company will not be liable in any such case if and to the extent that any such Loss arises out of
or is based upon an untrue statement or alleged untrue statement or omission or alleged omission so
made in conformity with information furnished by such Holder Indemnified Person in writing
specifically for use in the

10

 

Shelf Registration Statement, or prospectus supplement, as applicable. Such indemnity shall
remain in full force and effect regardless of any investigation made by or on behalf of such Holder
Indemnified Person, and shall survive the transfer of such securities by the Holder.

          6.2 By the Holder. The Holder agrees to indemnify and hold harmless the Company, its
directors, officers, employees and agents and each Person, if any, who controls the Company within
the meaning of the Securities Act or of the Exchange Act, and its directors, officers, employees
and agents, (the “Company Indemnified Persons”) against any Losses to which such Company
Indemnified Person may become subject under the Securities Act, the Exchange Act or otherwise,
insofar as such Losses (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon (i) any untrue statement or alleged untrue statement of any
material fact (in the case of any prospectus, in light of the circumstances under which such
statement is made) contained in information regarding the Holder, furnished in writing by or on
behalf of the Holder expressly for inclusion in the Shelf Registration Statement, any preliminary
prospectus, prospectus supplement or final prospectus contained therein, or any amendment or
supplement thereof, (ii) any misrepresentation or breach of any representation or warranty made by
the Holder in this Agreement or (iii) any breach of any covenant, agreement or obligation of the
Holder contained in this Agreement; provided, however, that the liability of the Holder shall not
be greater in amount than the dollar amount of the proceeds (net of any Selling Expenses) received
by the Holder from the sale of the Registrable Securities giving rise to such indemnification.

          6.3 Notice. Promptly after receipt by an indemnified party hereunder of notice of the
commencement of any action, such indemnified party shall, if a claim in respect thereof is to be
made against the indemnifying party hereunder, notify the indemnifying party in writing thereof,
but the omission to so notify the indemnifying party shall not relieve it from any liability which
it may have to any indemnified party other than under this Section 6. In any action
brought against any indemnified party, it shall notify the indemnifying party of the commencement
thereof. The indemnifying party shall be entitled to participate in and, to the extent it shall
wish, to assume and undertake the defense thereof with counsel reasonably satisfactory to such
indemnified party and, after notice from the indemnifying party to such indemnified party of its
election to so assume and undertake the defense thereof, the indemnifying party shall not be liable
to such indemnified party under this Section 6 for any legal expenses subsequently incurred
by such indemnified party in connection with the defense thereof other than reasonable costs of
investigation and of liaison with counsel so selected; provided, however, that, (i) if the
indemnifying party has failed to assume the defense or employ counsel reasonably acceptable to the
indemnified party or (ii) if the defendants in any such action include both the indemnified party
and the indemnifying party and counsel to the indemnified party shall have concluded that there may
be reasonable defenses available to the indemnified party that are different from or additional to
those available to the indemnifying party, or if the interests of the indemnified party reasonably
may be deemed to conflict with the interests of the indemnifying party, then the indemnified party
shall have the right to select a separate counsel and to assume such legal defense and otherwise to
participate in the defense of such action, with the reasonable expenses and fees of such separate
counsel and other reasonable expenses related to such participation to be reimbursed by the
indemnifying party as incurred. Notwithstanding any other provision of this Agreement, no
indemnifying party shall settle any action brought against any indemnified party with respect to
which such indemnified party is entitled to

11

 

indemnification hereunder without the consent of the indemnified party, unless the settlement
thereof imposes no liability or obligation on, and includes a complete and unconditional release
from all liability of, the indemnified party.

          6.4 Contribution. If the indemnification provided for in this Section 6 is
held by a court or government agency of competent jurisdiction to be unavailable to any indemnified
party or is insufficient to hold them harmless in respect of any Losses, then each such
indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount
paid or payable by such indemnified party as a result of such Loss in such proportion as is
appropriate to reflect the relative fault of the indemnifying party on the one hand and of such
indemnified party on the other in connection with the statements, omissions or conduct that
resulted in such Losses, as well as any other relevant equitable considerations; provided, however,
that in no event shall the Holder be required to contribute an aggregate amount in excess of the
dollar amount of proceeds (net of Selling Expenses) received by the Holder from the sale of
Registrable Securities giving rise to such indemnification. The relative fault of the indemnifying
party on the one hand and the indemnified party on the other shall be determined by reference to,
among other things, whether the untrue or alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact has been made by, or relates to, information
supplied by such party, and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission. The parties hereto agree that it
would not be just and equitable if contributions pursuant to this paragraph were to be determined
by pro rata allocation or by any other method of allocation which does not take account of the
equitable considerations referred to herein. The amount paid by an indemnified party as a result
of the Losses referred to in the first sentence of this paragraph shall be deemed to include any
legal and other expenses reasonably incurred by such indemnified party in connection with
investigating or defending any Loss which is the subject of this paragraph. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to contribution from any Person who is not guilty of such fraudulent misrepresentation.

          6.5 Other Indemnification. The provisions of this Section 6 shall be in
addition to any other rights to indemnification or contribution which an indemnified party may have
pursuant to law, equity, contract or otherwise.

     7. Rule 144 Reporting. With a view to making available the benefits of certain rules
and regulations of the Commission that may permit the sale of the Registrable Securities to the
public without registration, during the Effectiveness Period, the Company agrees to use its
commercially reasonable efforts to:

          7.1 Make and keep public information regarding the Company available, as those terms are
understood and defined in Rule 144 under the Securities Act, at all times from and after the date
hereof;

          7.2 File with the Commission in a timely manner all reports and other documents required to be
filed by the Company under the Securities Act and the Exchange Act at all times from and after the
date hereof; and

12

 

          7.3 So long as the Holder owns any Registrable Securities, furnish, unless otherwise available
via EDGAR, to the Holder forthwith upon request a copy of the most recent annual or quarterly
report of the Company, and such other reports and documents so filed as the Holder may reasonably
request in availing itself of any rule or regulation of the Commission allowing the Holder to sell
any such securities without registration.

     8. Conditions to the Company’s Obligation to Consummate Transaction. The obligation
of the Company to consummate the Transaction is subject to the satisfaction or waiver, at or prior
to the Closing Date, of the following conditions:

          8.1 The representations and warranties of the Holder set forth in this Agreement shall be true
and correct in all respects on the date of this Agreement and on the Closing Date, as if made on
the Closing Date, and on or before such Closing Date, the Holder shall have performed in all
respects the covenants and agreements of the Holder required to be performed by the Holder on or
before the Closing Date.

     9. Conditions to the Holder’s Obligation to Consummate Transaction. The obligation of
the Holder to consummate the Transaction is subject to the satisfaction or waiver, at or prior to
the Closing Date, of the following conditions:

          9.1 The representations and warranties of the Company set forth in this Agreement shall be
true and correct in all respects on the date of this Agreement and on such Closing Date, as if made
on such Closing Date, and on or before such Closing Date, the Company shall have performed in all
respects the covenants and agreements of the Company required to be performed by the Company on or
before such Closing Date.

     10. Miscellaneous.

          10.1 Any provision of this Agreement may be amended or waived if such amendment or waiver is
in writing and is signed, in the case of an amendment, by each party to this Agreement, or in the
case of a waiver, by the party against whom the waiver is to be effective.

          10.2 No failure or delay by any party in exercising any right, power or privilege hereunder
shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any
other or further exercise thereof or the exercise of any other right, power or privilege. The
rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies
provided by law.

          10.3 This Agreement shall be binding on and inure to the benefit of each party hereto and his
or its legal representatives, successors and assigns; provided, however, Holder may not assign its
rights pursuant to Section 5 without the prior written consent of the Company.

          10.4 This Agreement shall be governed by and construed in accordance with the law of the State
of New York, without regard to the conflicts of law rules of such state.

          10.5 The representations and warranties contained herein shall survive for one year following
the Closing Date.

13

 

          10.6 All notices and other communications relating to this Agreement shall be dated and in
writing and shall be deemed to have been duly given when delivered, if delivered personally or sent
by registered or certified mail, return receipt requested, postage prepaid, and when received if
delivered otherwise, to the party to whom it is directed:

          If to the Company, to the Company at the following address:

Resolute Energy Corporation

1675 Broadway

Suite 1950

Denver, CO 80202

Attn: Michael N. Stefanoudakis, General Counsel

Fax: (303) 623-3628

          With a copy to:

Davis, Graham & Stubbs LLP

1550 17th Street, Suite 500

Denver, CO 80202

Attn: Ronald R. Levine, II

Fax: (303) 892-7400

          If to the Holder, to the Holder at the following address:

[_____________]

c/o Pine River Capital Management L.P.

601 Carlson Parkway

Suite 330

Minnetonka, MN 55305

Attn: Timothy O’Brien, General Counsel

Fax: 612-238-3301

          10.7 This Agreement may be signed in any number of counterparts, each of which shall be an
original, with the same effect as if the signatures thereto and hereto were upon the same
instrument.

          10.8 The headings contained in this Agreement are for reference purposes only and shall not in
any way affect the meaning or interpretation of this Agreement.

          10.9 This Agreement constitutes the entire agreement between and among the parties with
respect to the subject matter of this Agreement and supersedes all prior agreements and
understandings, both oral and written, between and among the parties with respect to the subject
matter hereof and thereof. No provision of this Agreement is intended to confer upon any person
other than the parties hereto any rights or remedies hereunder.

          10.10 In case any provision of this Agreement shall be invalid, illegal or unenforceable, the
validity, legality and enforceability of the remaining provisions shall not in any way be affected
or impaired thereby.

14

 

          10.11 Each party hereto shall promptly execute and deliver such further agreements and
instruments, and take such further actions, as the other party may reasonably request in order to
carry out the purpose and intent of this Agreement.

15

 

     IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of the
date first above written.

	 	 	 	 	 	 	 	 	 

	 	 	RESOLUTE ENERGY CORPORATION, a Delaware corporation	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Name:	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	[_______________]	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	By:	 	Pine River Capital Management L.P.,	 	 
	 	 	Its Investment Manager	 	 
	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 

	 	 	 	Name:	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00179-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00179-of-00352.parquet"}]]